Free Trial
NASDAQ:WORX

SCWorx Q3 2025 Earnings Report

SCWorx logo
$0.26 -0.04 (-11.83%)
As of 06/9/2026 01:36 PM Eastern

SCWorx EPS Results

Actual EPS
-$2.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

SCWorx Revenue Results

Actual Revenue
$0.71 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

SCWorx Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

SCWorx Earnings Headlines

80X Growth in ONE Quarter (Read before June 16)
Marc Chaikin - creator of one of Wall Street's most widely used indicators - is sounding the alarm on a pre-IPO AI lab that saw revenue surge 80-fold in a single quarter, putting it on pace to outsell OpenAI and SpaceX combined. The company, now valued at $965 billion, is expected to debut publicly this fall. But Chaikin believes a June 16 announcement tied to its internal 'Project Tengu' could push that valuation significantly higher - and he's identified a $40 backdoor play available right now.tc pixel
SCWorx Corp. Common Stock (WORX)
SCWorx Corp.
See More SCWorx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SCWorx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SCWorx and other key companies, straight to your email.

About SCWorx

SCWorx (NASDAQ:WORX) develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion, and automation; electronic medical record management; charge description master management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.

View SCWorx Profile